Filgrastim XM02 (Tevagrastim®) after autologous stem cell transplantation compared to lenograstim: favourable cost-efficacy analysis

PURPOSE: Granulocyte colony-stimulating factors (G-CSFs), filgrastim and lenograstim, are recognised to be useful in accelerating engraftment after autologous stem cell transplantation. Several forms of biosimilar non-glycosylated G-CSF have been approved by the European Medicines Agency, with limit...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Gardellini, A, Gigli, F, Babic, A, Andreola, G, Radice, D, Sammassimo, S, Martinelli, G, Laszlo, D
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Cancer Intelligence 2013
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3694838/
https://ncbi.nlm.nih.gov/pubmed/23818939
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2013.327
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller